Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Anti-inflammatory Pain Relief Gel
Diclofenac sodium 10mg/g
Topical gel
PSM Healthcare Limited trading as API Consumer Brands
PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Aspec
Aspirin 100mg
Enteric coated tablet
Medreich New Zealand Limited
Medreich Limited, Bangalore, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Medreich Aspirin EC
Aspirin 100mg
Enteric coated tablet
Medreich New Zealand Limited
Medreich Limited, Bangalore, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Pravastatin Mylan
Pravastatin sodium 10mg
Tablet
Mylan New Zealand Limited
Intas Pharmaceuticals Limited, Sanand, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Pravastatin Mylan
Pravastatin sodium 20mg
Tablet
Mylan New Zealand Limited
Intas Pharmaceuticals Limited, Sanand, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Pravastatin Mylan
Pravastatin sodium 40mg
Tablet
Mylan New Zealand Limited
Intas Pharmaceuticals Limited, Sanand, India
|
Dated this 17th day of April 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz